Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascension Medical Biotechnology (AM BioTech) is a Taiwan-based biotechnology company specializing in the research, development, and manufacturing of high-purity exosomes and extracellular vesicles. The company utilizes its proprietary Bio-Pulsed technology to induce stem cells to produce functional exosomes with enhanced efficacy for applications in aesthetics, regenerative medicine, and drug delivery. Its flagship product, ExoGiov®, is an INCI-certified cosmetic ingredient used for skin repair and hair volumizing, recognized for its room-temperature stability and high purity. AM BioTech is also advancing a therapeutic pipeline targeting conditions such as degenerative arthritis, hearing loss, and macular degeneration through academic and clinical collaborations. The company provides CDMO services for exosome production, leveraging its patented ultra-purification and mass production processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AM Bio.